Daniel Stauder
Stock Analyst at JMP Securities
(4.60)
# 216
Out of 4,974 analysts
18
Total ratings
70.59%
Success rate
20.9%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Daniel Stauder
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AORT Artivion | Maintains: Market Outperform | $33 → $42 | $44.03 | -4.61% | 5 | Aug 8, 2025 | |
| ATRC AtriCure | Reiterates: Market Outperform | $60 | $35.66 | +68.26% | 6 | Apr 30, 2025 | |
| STIM Neuronetics | Maintains: Market Outperform | $3 → $7 | $3.31 | +111.48% | 1 | Mar 5, 2025 | |
| LMAT LeMaitre Vascular | Maintains: Buy | $105 → $110 | $97.07 | +13.32% | 4 | Feb 28, 2025 | |
| AXON Axon Enterprise | Reiterates: Market Outperform | $725 | $730.16 | -0.71% | 1 | Feb 26, 2025 | |
| AVNS Avanos Medical | Reiterates: Market Perform | n/a | $12.66 | - | 1 | May 7, 2024 |
Artivion
Aug 8, 2025
Maintains: Market Outperform
Price Target: $33 → $42
Current: $44.03
Upside: -4.61%
AtriCure
Apr 30, 2025
Reiterates: Market Outperform
Price Target: $60
Current: $35.66
Upside: +68.26%
Neuronetics
Mar 5, 2025
Maintains: Market Outperform
Price Target: $3 → $7
Current: $3.31
Upside: +111.48%
LeMaitre Vascular
Feb 28, 2025
Maintains: Buy
Price Target: $105 → $110
Current: $97.07
Upside: +13.32%
Axon Enterprise
Feb 26, 2025
Reiterates: Market Outperform
Price Target: $725
Current: $730.16
Upside: -0.71%
Avanos Medical
May 7, 2024
Reiterates: Market Perform
Price Target: n/a
Current: $12.66
Upside: -